126 related articles for article (PubMed ID: 18201513)
1. Intravitreal pharmacotherapy: applications in retinal disease.
Prasad AG; Schadlu R; Apte RS
Compr Ophthalmol Update; 2007; 8(5):259-69. PubMed ID: 18201513
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal steroids for macular edema: the past, the present, and the future.
Cunningham MA; Edelman JL; Kaushal S
Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
[TBL] [Abstract][Full Text] [Related]
3. Novel drug delivery systems for retinal diseases. A review.
Lee SS; Robinson MR
Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal steroids for macular edema.
Grosso A; Panico C
Surv Ophthalmol; 2009; 54(3):426; author reply 426-7. PubMed ID: 19422970
[No Abstract] [Full Text] [Related]
5. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Grenga P; Lupo S; Domanico D; Vingolo EM
Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
[TBL] [Abstract][Full Text] [Related]
6. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
Wickremasinghe SS; Rogers SL; Gillies MC; Zhu M; Wong TY
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4707-11. PubMed ID: 18599569
[TBL] [Abstract][Full Text] [Related]
7. [Uveitic macular edema].
Fardeau C; Champion E; Massamba N; LeHoang P
J Fr Ophtalmol; 2015 Jan; 38(1):74-81. PubMed ID: 25547721
[TBL] [Abstract][Full Text] [Related]
8. Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration.
Querques G; Souied EH; Soubrane G
Acta Ophthalmol; 2009 Mar; 87(2):235-7. PubMed ID: 19292858
[No Abstract] [Full Text] [Related]
9. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
10. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
Campbell M; Doyle SL
Biochem Pharmacol; 2019 Jun; 164():321-325. PubMed ID: 31039332
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
13. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
[TBL] [Abstract][Full Text] [Related]
14. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
16. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation.
Freund KB; Ho IV; Barbazetto IA; Koizumi H; Laud K; Ferrara D; Matsumoto Y; Sorenson JA; Yannuzzi L
Retina; 2008 Feb; 28(2):201-11. PubMed ID: 18301024
[TBL] [Abstract][Full Text] [Related]
17. [Retina and glaucoma: therapeutic considerations].
Aptel F; Denis P
J Fr Ophtalmol; 2008 Jul; 31(6 Pt 2):2S61-4. PubMed ID: 18957916
[TBL] [Abstract][Full Text] [Related]
18. Complications of intravitreal triamcinolone acetonide.
Erol N; Topba S
Surv Ophthalmol; 2009; 54(3):427; author reply 427-8. PubMed ID: 19422973
[No Abstract] [Full Text] [Related]
19. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Er H
Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
[No Abstract] [Full Text] [Related]
20. Intravitreal injection of therapeutic agents.
Peyman GA; Lad EM; Moshfeghi DM
Retina; 2009; 29(7):875-912. PubMed ID: 19584648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
